uniQure (QURE) Asset Utilization Ratio (2017 - 2026)

uniQure (QURE) recorded quarterly Asset Utilization Ratio of 0.02 in Q1 2026, up 20.08% quarter-over-quarter from 0.02 in Q4 2025, and down 35.1% on a YoY basis from 0.03 in Q1 2025.

uniQure (QURE) Asset Utilization Ratio (2017 - 2026) Analysis & Trends

uniQure's Asset Utilization Ratio history runs 10 years deep, the most recent figure standing at 0.02 for Q1 2026.

  • In Q1 2026, Asset Utilization Ratio fell 35.1% year-over-year to 0.02; the TTM figure through Mar 2026 stood at 0.02 (down 35.1% YoY), while the FY2025 annual figure was 0.02, down 40.35% from the prior year.
  • Asset Utilization Ratio was 0.02 for Q1 2026 at uniQure, up from 0.02 in the prior quarter.
  • In the past five years, Asset Utilization Ratio ranged from a high of 0.67 in Q1 2022 to a low of 0.02 in Q4 2023.
  • Historically, Asset Utilization Ratio has averaged 0.1 across 5 years, with a median of 0.04 in 2024.
  • Biggest YoY gain for Asset Utilization Ratio was 523.82% in 2022; the steepest drop was 90.25% in 2022.
  • A 5-year view of Asset Utilization Ratio shows it stood at 0.16 in 2022, then slumped by 88.27% to 0.02 in 2023, then surged by 142.48% to 0.05 in 2024, then sank by 58.34% to 0.02 in 2025, then increased by 20.08% to 0.02 in 2026.
  • The last three Asset Utilization Ratio figures came in at 0.02 (Q1 2026), 0.02 (Q4 2025), and 0.02 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Asset Util. (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn - 0.55
2 Belite Bio 58,560.00 Bn 58,560.00 Bn - -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn - -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn 0.60
5 Evaxion A 1,334.43 Bn 1,334.42 Bn - 1,422.00
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn - -
7 Psyence Biomedical 212.16 Bn 212.16 Bn - -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn 0.47
9 Abivax 91.96 Bn 91.96 Bn - -
10 uniQure 2.88 Bn 2.88 Bn 3.34 Mn 0.02

Historic Data

Download Data
DateValue
Mar 31, 2026 0.02
Dec 31, 2025 0.02
Sep 30, 2025 0.02
Jun 30, 2025 0.02
Mar 31, 2025 0.03
Dec 31, 2024 0.05
Sep 30, 2024 0.04
Jun 30, 2024 0.04
Mar 31, 2024 0.02
Dec 31, 2023 0.02
Sep 30, 2023 0.12
Jun 30, 2023 0.14
Mar 31, 2023 0.16
Dec 31, 2022 0.16
Sep 30, 2022 0.09
Jun 30, 2022 0.08
Mar 31, 2022 0.67
Dec 31, 2021 0.66
Sep 30, 2021 0.64
Jun 30, 2021 0.87